Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Adam Wilczok"'
Autor:
Alicja Zajdel, Adam Wilczok
Publikováno v:
Farmacja Polska, Vol 79, Iss 6, Pp 347-354 (2023)
The gut microbiota forms a complex and metabolically active ecosystem. Changes in gut microbiota activity correlate with the health status.. It is not known whether the dysfunction of the intestinal microbiota due to undesirable changes in the qualit
Externí odkaz:
https://doaj.org/article/e0a61480689644f7a16e4f8ee3b57597
Autor:
Alicja Zajdel, Adam Wilczok
Publikováno v:
Acta Poloniae Pharmaceutica, Vol 80, Iss 5, Pp 747-747 (2023)
Doxorubicin (DOX) still remains one the most effective a clinical drug for breast cancer treatment. Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), the n-3 polyunsaturated fatty acids (PUFAs), exert pronounced toxicity against many types
Externí odkaz:
https://doaj.org/article/329a6d5c811b4a95b1e43de1a18df159
Autor:
Katarzyna Jelonek, Alicja Zajdel, Adam Wilczok, Bożena Kaczmarczyk, Monika Musiał-Kulik, Anna Hercog, Aleksander Foryś, Małgorzata Pastusiak, Janusz Kasperczyk
Publikováno v:
Pharmaceutics, Vol 13, Iss 11, p 1881 (2021)
Co-delivery of epothilone B (EpoB) and rapamycin (Rap) increases cytotoxicity against various kinds of cancers. However, the current challenge is to develop a drug delivery system (DDS) for the simultaneous delivery and release of these two drugs. Ad
Externí odkaz:
https://doaj.org/article/e4abe9fdd13c44818142c4de5275a8a5
Autor:
Alicja Zajdel, Adam Wilczok, Katarzyna Jelonek, Monika Musiał-Kulik, Aleksander Foryś, Suming Li, Janusz Kasperczyk
Publikováno v:
Pharmaceutics, Vol 11, Iss 4, p 169 (2019)
To find better strategies to enhance the cytotoxic effect of paclitaxel (PTX) and lapatinib (LAP) against breast cancer cells, we analyzed the efficacy of a novel delivery system containing polylactide-co-poly(ethylene glycol) (PLA-PEG) filomicelles
Externí odkaz:
https://doaj.org/article/94a243a39b39481d9a661d0ad66c7b07
Autor:
Alicja Zajdel, Monika Musiał-Kulik, Adam Wilczok, Janusz Kasperczyk, Katarzyna Jelonek, Anna Kaps
Publikováno v:
Journal of Biomedical Materials Research Part A. 109:1693-1700
The new therapeutic solutions for breast cancer treatment are needed, for example, combined therapy consisted of several drugs that characterize different mechanisms of action and modern drug delivery systems. Therefore, we used combination of epothi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c1502ce881866f8440161cbd7a68a19
https://doi.org/10.1002/jbm.a.37164
https://doi.org/10.1002/jbm.a.37164
Autor:
Monika Musiał-Kulik, Anna Hercog, Adam Wilczok, Katarzyna Jelonek, Alicja Zajdel, Aleksander Foryś, Janusz Kasperczyk, Bozena Kaczmarczyk, Małgorzata Pastusiak
Publikováno v:
Pharmaceutics, Vol 13, Iss 1881, p 1881 (2021)
Pharmaceutics
Volume 13
Issue 11
Pharmaceutics
Volume 13
Issue 11
Co-delivery of epothilone B (EpoB) and rapamycin (Rap) increases cytotoxicity against various kinds of cancers. However, the current challenge is to develop a drug delivery system (DDS) for the simultaneous delivery and release of these two drugs. Ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35afe696dc7d312ca9394c071c997afa
https://www.mdpi.com/1999-4923/13/11/1881
https://www.mdpi.com/1999-4923/13/11/1881
Publikováno v:
Postępy Higieny i Medycyny Doświadczalnej, Vol 73, Pp 508-515 (2019)
Despite significant progress in the last few decades in breast cancer biology and the use of different therapeutic strategies, this cancer remains a serious clinical problem. Paclitaxel (PTX) is used to treat breast cancer both as a monotherapy and i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::729ce295f1c2115d9f8ab9db87d0a9fb
https://doi.org/10.5604/01.3001.0013.5251
https://doi.org/10.5604/01.3001.0013.5251
Publikováno v:
Toxicology in vitro : an international journal published in association with BIBRA. 75
Paclitaxel (PTX) is used to treat breast cancer both as a monotherapy and in combination with other anticancer drugs. Chemoresistance is one of the main reasons for the failure of breast cancer treatment. Mechanisms which contribute to multidrug resi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de632c5fab1cbfaa6605ae36d346738d
https://pubmed.ncbi.nlm.nih.gov/34126209
https://pubmed.ncbi.nlm.nih.gov/34126209
Autor:
Janusz Kasperczyk, Adam Wilczok, Monika Musiał-Kulik, Katarzyna Jelonek, Małgorzata Latocha, Alicja Zajdel, Aleksander Foryś
Publikováno v:
Materials Letters. 241:187-189
Polymeric micelles have been widely studied and developed for targeted delivery of cytostatic drugs. However, due to heterogeneity of tumor cells, targeting efficiency may be enhanced by using different types of targeting agents on the same drug deli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6422a19341bcf1b479d9b56de5d78dd
https://doi.org/10.1016/j.matlet.2019.01.081
https://doi.org/10.1016/j.matlet.2019.01.081
Autor:
Janusz Kasperczyk, Adam Wilczok, Katarzyna Jelonek, Aleksander Foryś, Suming Li, Monika Musiał-Kulik, Alicja Zajdel
Publikováno v:
Pharmaceutics
Pharmaceutics, MDPI, 2019, 11 (4), pp.169. ⟨10.3390/pharmaceutics11040169⟩
Pharmaceutics, Vol 11, Iss 4, p 169 (2019)
Volume 11
Issue 4
Pharmaceutics, MDPI, 2019, 11 (4), pp.169. ⟨10.3390/pharmaceutics11040169⟩
Pharmaceutics, Vol 11, Iss 4, p 169 (2019)
Volume 11
Issue 4
International audience; To find better strategies to enhance the cytotoxic effect of paclitaxel (PTX) and lapatinib (LAP) against breast cancer cells, we analyzed the efficacy of a novel delivery system containing polylactide-co-poly(ethylene glycol)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d62fff342158d725d9742c401406e956
https://hal.archives-ouvertes.fr/hal-03085176/file/Li20-kasia-pharmaceutics-11-00169.pdf
https://hal.archives-ouvertes.fr/hal-03085176/file/Li20-kasia-pharmaceutics-11-00169.pdf
